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Introduction: Primary paraganglioma of the lung is a rare tumor of which few cases are reported in literature. Both
solitary and diffuse primary pulmonary paragangliomas are described. The solitary form of this tumor is rare.
Case presentation: We report the case of a 63-year-old Caucasian man with cough, intermittent palpitations and
dyspnea. A contrast-enhanced computed tomography scan of his chest revealed a rounded, high-density lesion
with irregular profiles measuring 24mm in diameter in the middle lobe. The lesion was suggestive of malignancy.
Fine-needle aspiration cytology was performed. The results of the cytological tests were positive for malignant cells.
Surgical resection was the choice of treatment. The results of the biochemical tests and postoperative histological
examination allowed a definitive diagnosis: primary pulmonary paraganglioma.
Conclusions: Paragangliomas are identified and characterized with the use of computed tomography and other
imaging methods, but for a definitive diagnosis, histopathological evaluation is necessary.
We report a rare case of a primary pulmonary paraganglioma that was treated surgically. This case report adds
valuable knowledge to the literature on pulmonary paragangliomas.
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Paragangliomas are rare tumors that arise from extra-
adrenal chromaffin cells. They represent 10–18% of all
chromaffin tissue-related tumors, which are reported at a
rate of 2–8 cases/million a year [1]. Paragangliomas of the
head, neck and mediastinum are usually associated with the
parasympathetic system, and are chromaffin negative; they
do not secrete catecholamines and do not present with epi-
sodic hypertension and other suggestive symptoms [2]. Pri-
mary pulmonary paragangliomas are rare [2]. Few cases of
primary pulmonary paraganglioma have been reported
since the first report by Heppleston in 1958 [3]. Erickson et
al., in 2001, describe 28 cases of thoracic paragangliomas
since 1978 (19 in the lung parenchyma). The majority
(86%) of the paragangliomas below the neck were pulmon-
ary parenchymal incidentalomas that were described as in-
determinate nodules on imaging studies of the chest [4].
Pulmonary paragangliomas are difficult to differentiate
from bronchial carcinomas and metastatic tumors. Imaging
studies are important to confirm a clinical suspicion of* Correspondence: Giuseppefiorentino1@gmil.com
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quent treatment plan. However, according to the data re-
ported in the literature, histopathological evaluation is
necessary for a definitive diagnosis. The present case de-
scribes an unexpected diagnosis of a very rare cancer.
Case presentation
We report the case of a 63-year-old Caucasian man who
presented with cough, intermittent palpitations and dys-
pnea. Our patient had a history of smoking. His blood
pressure was normal, as were the results of clinical la-
boratory examinations. Our patient was subjected to a
respiratory functional study that showed a moderate,
nonreversible obstructive syndrome (forced expiratory
volume in the first second (FEV1) 58%); arterial blood
gas analysis showed normal oxygen saturation. A chest
X-ray showed a lesion in the right lung field (Fig. 1a).
A contrast-enhanced computed tomography (CT) scan
of his chest revealed a rounded, high-density lesion with
irregular profiles with a diameter of 24mm in the middle
lobe, (Fig. 1b). An abdominal ultrasound scan and cervical
CT scan revealed no abnormalities. The lesion was
scanned by positron emission tomography (PET)/CT. Therticle is distributed under the terms of the Creative Commons Attribution
mons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
you give appropriate credit to the original author(s) and the source,
ense, and indicate if changes were made. The Creative Commons Public
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Fig. 1 Radiological images of the pulmonary nodule. Chest X-ray showing a lesion in the right lung field (a). Contrast-enhanced computed
tomography scan of the chest revealing a rounded, high-density lesion with irregular profiles with a diameter of 24mm in the middle lobe (b).
Fine-needle aspiration (c)
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take into the pulmonary lesion. Standardized uptake values
(SUV) measured 2.8. Bronchofibroscopy did not show exter-
nal pressure or visible alterations. Conventional and brush
biopsies did not find cancer cells. Fine-needle aspiration cy-
tology was performed (Fig. 1c). The results of the cytological
tests were positive for not otherwise specified (NOS) neuro-
endocrine carcinoma. The immunohistochemistry test re-
sults were positive for cytokeratin (CK) AE1\AE3 and natural
killer cell-associated antigen CD56, negative for thyroid tran-
scription factor-1 (TTF-1), P63, and leukocyte common anti-
gen (LCA). It was not possible to perform octreoscan
scintigraphy due to the long waiting times envisaged.
After 30 days of therapy with long-acting beta-2 ago-
nists, inhaled corticosteroids plus anticholinergic drugs,
and a pulmonary rehabilitation cycle, the thoracic surgeon
examined our patient and decided upon subsegmentect-
omy for histological confirmation, this type of intervention
allowing a wide margin of resection free of tumor. The le-
sion was located in the medial segment of the middle lobe:
the pulmonary hilum was surrounded by fibrous tissue
that makes it difficult to isolate the vessels. Samples of
pericardial fluid and serum blood were collected for cyto-
logical examination; micronodules were present, of which
the largest was removed for histological examination. In
the context of this fibrous tissue was also a small lymph
node station 4R, which extemporaneous histological
examination proved to be likely metastatic infiltration. It
was removed for definitive examination.
Our patient was treated with subsegmentectomy for
histological confirmation and because intraoperative fro-
zen sections showed a malignant neoplasm, it was com-
pleted by lobectomy of the right middle lobe andcomplete lymphadenectomy. Extemporaneous histological
examination of a pericardial micro vegetation (hyaline
plaque) and lymph node station 4R (a lymph node with
small parenchymal nodules composed of spindle cells and
ovoid in chromatin suspected of widespread metastases)
was also performed. The definitive histological examin-
ation of the nodular lesion showed a tumor with an orga-
noid pattern (Fig. 2a).
At immunohistochemical staining, the cell popula-
tion was positive for neuron-specific enolase (NSE),
chromogranin, synaptophysin, natural killer cell-
associated antigens CD56 and CD57, glial fibrillary
acid protein (GFAP), negative for CK, epithelial mem-
brane antigen (EMA), and TTF-1 (Fig. 2b, c, d); the
protein s100 has marked the base of the nests’
neoplastic cells (Fig. 2e). The definitive diagnosis was
paraganglioma of the middle lobe pT1b pN0 cM0. The
lymph node was negative for malignant neoplasm; the
diagnosis was small leiomyoma (+ s100-actin). In subse-
quent follow-ups at six months and at one year, our
patient showed no problems.
Discussion
Our patient’s medical history and the radiological studies
performed showed a solitary pulmonary nodule with a
risk of malignancy of 81.5% [5]. CT-guided fine-needle
aspiration cytology was performed with evidence of
NOS neuroendocrine carcinoma. Pulmonary aspiration
as a diagnostic technique has a sensitivity of 90% and a
specificity of 97% [6]. With the diagnosis of cancer sug-
gestive of malignancy, he was examined by the thoracic
surgeon. His moderate degree of obstructive syndrome
was treated pharmacologically and with pulmonary
Fig. 2 Histology of the nodule. The definitive histological examination of the nodular lesion, showed a tumor with an organoid pattern (a). At
immunohistochemical staining, the cell population was positive for NSE, chromogranin, synaptophysin, natural killer cell-associated antigens CD56
and CD57, GFAP, and negative for CK, EMA, TTF-1 (b, c, d); the protein s100 has marked the base of the nests’ neoplastic cells (e). CK cytokeratin,
EMA epithelial membrane antigen, GFAP glial fibrillary acid protein, NSE neuron-specific enolase, TTF-1 thyroid transcription factor-1
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Primitive lung paragangliomas are often discovered inci-
dentally with examination of routine chest radiographs,
and patients are free of symptoms and hypertension. Ac-
cording to the literature about 10% of paragangliomas are
malignant and all patients have been treated surgically
with either local excision or lobectomy [7]. There are,
however, no histological or biochemical markers that can
reliably predict the malignant tendency of these tumors.
The recent reclassification of neuroendocrine neoplasms
of the lung shows that in this context neuroendocrine candifferentiate several groups of diseases (tumorlets, carci-
noids, small cell lung carcinoma, and large cell neuroen-
docrine carcinoma) [8].Conclusions
In this case report we highlight the presentation of a rare
cancer as primary paraganglioma of the lung. Pulmonary
paraganglioma is very similar to carcinoid neuroendocrine
tumor, in fact in the preparation cytology, neuroendocrine
markers were present. Often the cytology cannot allow
easy differentiation of large cell neuroendocrine carcinoma
from small cell cancer. Finally, only histopathological
examination allowed characterization of the lesion. The
biological behavior of these rare malignant neoplasms in
Fiorentino et al. Journal of Medical Case Reports  (2015) 9:166 Page 4 of 4the lung is generally favorable; however, we cannot predict
the histological parameters with any certainty.
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